The most prevalent driver mutations were in NOTCH1 in T-ALL and in the Ras signaling pathway (NRAS, KRAS, PTPN11 and FLT3) in BCP-ALL (Figure 2, Supplementary Figure S8). The gene discussed is KRAS; the disease is acute lymphoblastic leukemia.